Pulmonology 1
Trimester of pregnancy with most frequent asthma exacerbations
Second trimester
Possible complication during air travel in asthma or COPD
Pneumothorax
Physical manifestation of CSA due to heart failure
Cheyne-Stokes breathing
High-prevalence condition in young patients with DPLD
Connective tissue disease
Common drug cause of CSA
Opioids
Imaging for evaluation of solid lung nodule >8 mm
CT and PET
Pleural fluid LDH level in exudative pleural effusion
>2/3 upper limit of normal for serum LDH
Most common causes of pleural effusion
Heart failure, pneumonia, malignancy
Antibiotic class for severe COPD with frequent exacerbations
Macrolide
Conditions warranting in-lab polysomnography
Cardiopulmonary or neuromuscular disease
Diagnostic tests for allergic bronchopulmonary aspergillosis
Aspergillus-specific IgE and IgG; total IgE; Aspergillus antigen skin test; blood eosinophil
Drug treatments for high-altitude pulmonary edema
Nifedipine, PDE-5 inhibitor
Add-on therapy to short-acting bronchodilators in COPD
LABA and/or LAMA
Asthma monotherapy associated with increased mortality
LABA
Empiric antibiotic class for bronchiectasis exacerbation
Fluoroquinolone
Characteristics of idiopathic NSIP compared with IPF
Typically affects younger population, has more favorable prognosis
Treatment for CTEPH
Pulmonary thromboendarterectomy and anticoagulation
Most common causes of lymphocyte-predominant pleural effusion
TB, cancer
Role of sputum culture in COPD exacerbation
None
Symptoms and history suggestive of mesothelioma
Asbestos exposure, chest pain, night sweats, recurrent pleural effusion
Diagnosis suggested by environmental exposure, fever, fatigue, cough
Hypersensitivity pneumonitis
Anterior mediastinal mass entities
Thymoma, teratoma, lymphoma, thyroid
Noninvasive tool to quantify eosinophilic airway inflammation
Fractional exhaled nitric oxide test
First-line therapy for PAH if tolerated
Endothelin-1 receptor antagonist plus PDE-5 inhibitor
OHS defining parameter
Daytime hypercapnia